Home/Filings/4/0001179110-21-011226
4//SEC Filing

Michaels Lisa Anne 4

Accession 0001179110-21-011226

CIK 0001650664other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 4:10 PM ET

Size

4.8 KB

Accession

0001179110-21-011226

Insider Transaction Report

Form 4
Period: 2021-12-22
Michaels Lisa Anne
EVP/Chief Medical Officer
Transactions
  • Award

    Common Stock

    2021-12-22+4,24322,675 total
Footnotes (1)
  • [F1]Reflects the acquisition, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on June 2, 2021. The shares subject to the restricted stock unit award remain subject to time-based vesting conditions and will vest on June 2, 2022, subject to continued service.

Issuer

Editas Medicine, Inc.

CIK 0001650664

Entity typeother

Related Parties

1
  • filerCIK 0001830610

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:10 PM ET
Size
4.8 KB